Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Breast (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Puerto Rico6


Arizona6


Massachusetts3


South Dakota6


Vermont6


Texas3


New Mexico3


Rhode Island6


Arkansas6


Maine6


Alabama6


Michigan6


Oregon6


Wyoming6


Tennessee6


Connecticut3


Virginia6


Kansas6


California3


Utah3


Florida6


New Hampshire6


New York3


Kentucky3


West Virginia6


North Dakota6


Minnesota6


Hawaii3


Pennsylvania6


Colorado6


Nebraska6


Delaware6


Alaska6


Oklahoma6


Washington5


Montana6


South Carolina6


Iowa3


Wisconsin6


New Jersey3


Missouri6


Ohio6


Maryland6


Illinois3


North Carolina6


Idaho3


Mississippi6


District of Columbia6


Georgia3


Louisiana3


Indiana6 Nevada6

Notes:
Created by statecancerprofiles.cancer.gov on 07/23/2024 1:07 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.